Literature DB >> 24616311

The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

Terence W Friedlander1, Lawrence Fong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24616311     DOI： 10.1200/JCO.2013.54.7307

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture.

Authors:  Katarina Kolostova; Martin Cegan; Vladimir Bobek
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

2.  Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro.

Authors:  Melanie Arul; April Camilla Roslani; Swee Hung Cheah
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-01-24       Impact factor: 2.416

3.  Tissue-based biomarkers in prostate cancer.

Authors:  Timothy N Clinton; Aditya Bagrodia; Yair Lotan; Vitaly Margulis; Ganesh V Raj; Solomon L Woldu
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-09-05

4.  Emerging role of circulating tumor cells in cancer management.

Authors:  Michal Mego
Journal:  Indian J Med Paediatr Oncol       Date:  2014-10

Review 5.  Molecular pathways and targets in prostate cancer.

Authors:  Emma Shtivelman; Tomasz M Beer; Christopher P Evans
Journal:  Oncotarget       Date:  2014-09-15

Review 6.  Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review.

Authors:  Cristina Ligia Cebotaru; Elena Diana Olteanu; Nicoleta Zenovia Antone; Rares Buiga; Viorica Nagy
Journal:  Clujul Med       Date:  2016-04-15

7.  EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression.

Authors:  Arun Satelli; Izhar Batth; Zachary Brownlee; Abhishek Mitra; Shouhao Zhou; Hyangsoon Noh; Christina R Rojas; Heming Li; Qing H Meng; Shulin Li
Journal:  Oncotarget       Date:  2017-07-25

Review 8.  Liquid biopsy: a step forward towards precision medicine in urologic malignancies.

Authors:  Ashley Di Meo; Jenni Bartlett; Yufeng Cheng; Maria D Pasic; George M Yousef
Journal:  Mol Cancer       Date:  2017-04-14       Impact factor: 27.401

Review 9.  Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.

Authors:  Yoon Seok Suh; Jae Young Joung; Sung Han Kim; Ho Kyung Seo; Jinsoo Chung; Kang Hyun Lee
Journal:  Biomed Res Int       Date:  2017-11-05       Impact factor: 3.411

Review 10.  Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.

Authors:  Luis León-Mateos; María Vieito; Urbano Anido; Rafael López López; Laura Muinelo Romay
Journal:  Int J Mol Sci       Date:  2016-09-20       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.